Propanc Biopharma (PPCB) Exchange Rate Effect (2011 - 2025)
Propanc Biopharma (PPCB) posted quarterly Exchange Rate Effect of -$5192.0 for Q4 2025, up 92.38% year-over-year from -$2698.8 in Q4 2024, and down 195.53% quarter-over-quarter from $5435.0 in Q3 2025.
Propanc Biopharma (PPCB) Exchange Rate Effect (2011 - 2025) Analysis & Trends
Propanc Biopharma (PPCB) has reported Exchange Rate Effect for 15 consecutive years, with -$5192.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Exchange Rate Effect rose 92.38% year-over-year to -$5192.0; the TTM figure through Dec 2025 stood at -$34161.0 (up 47.92% YoY), while the FY2025 annual figure was -$94585.0, down 2319.26% from the prior year.
- Exchange Rate Effect fell to -$5192.0 in Q4 2025 per PPCB's latest filing, from $5435.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $95320.0 in Q3 2021 and bottomed at -$102366.0 in Q4 2021.
- Historically, Exchange Rate Effect has averaged -$7996.8 across 5 years, with a median of -$6610.0 in 2023.
- On a YoY basis, Exchange Rate Effect climbed as much as 1458.53% in 2021 and fell as far as 429.67% in 2021.
- Propanc Biopharma's Exchange Rate Effect stood at -$102366.0 in 2021, then surged by 80.76% to -$19693.0 in 2022, then jumped by 252.24% to $29981.0 in 2023, then sank by 327.41% to -$68180.0 in 2024, then jumped by 92.38% to -$5192.0 in 2025.
- Business Quant data shows PPCB's Exchange Rate Effect at -$5192.0 in Q4 2025, $5435.0 in Q3 2025, and -$19242.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | - |
| 10 | Propanc Biopharma | 577,167.14 | 577,167.14 | - | -5,192.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5,192.00 |
| Dec 31, 2025 | -5,192.00 |
| Sep 30, 2025 | 5,435.00 |
| Sep 30, 2025 | 5,435.00 |
| Jun 30, 2025 | -19,242.00 |
| Jun 30, 2025 | -19,242.00 |
| Mar 31, 2025 | -15,162.00 |
| Mar 31, 2025 | -15,162.00 |
| Dec 31, 2024 | -68,180.00 |
| Dec 31, 2024 | -68,180.00 |
| Sep 30, 2024 | 7,999.00 |
| Sep 30, 2024 | 7,999.00 |
| Jun 30, 2024 | 23,855.00 |
| Jun 30, 2024 | 23,855.00 |
| Mar 31, 2024 | -29,262.00 |
| Mar 31, 2024 | -29,262.00 |
| Dec 31, 2023 | 29,981.00 |
| Dec 31, 2023 | 29,981.00 |
| Sep 30, 2023 | -20,312.00 |
| Sep 30, 2023 | -20,312.00 |